Prevention of pneumonIA in Nursing hOme
PIANO
1 other identifier
interventional
3,818
1 country
1
Brief Summary
Infections in nursing home are associated with high morbidity and mortality. Pulmonary infections are known to be the most problematic. In our INCUR observational study of 773 residents, 20.13% of residents had pneumonia during the year of follow-up. On average, the extra cost of pneumopathies was 4,467 euros / patient for the long-term care facility and 3,044 euros for the hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2019
CompletedFirst Posted
Study publicly available on registry
October 9, 2019
CompletedStudy Start
First participant enrolled
October 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2023
CompletedJune 18, 2023
June 1, 2023
2.6 years
August 19, 2019
June 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The comparison of the incidence of lung disease number between the two groups
After the one-year : to compare of the incidence of lung disease between the two groups of Nursing home (the on-line formation/casual care) The diagnosis of pneumopathy will be defined on the criteria of the Infectious Risk Observatory in Geriatrics that are appropriate for nursing home residents, with at least two of the criteria defined for pneumonia
1 year
Number of Medical evidence of rattles or crepitates
Medical evidence of rattles or crepitates on chest auscultation : rattles or crepitates are criteria for the diagnosis of pneumopathy
1 year
Secondary Outcomes (5)
Establish a differential cost-effectiveness ratio at 1 year of the care of the residents in nursing home
1 year
Evaluation of the time spent by the health care team to support the patient between two groups
1 year
Evaluating the incidence of all-cause hospitalizations
1 year
Evaluate the evolution of quality of care indicators in the nursing home
1 year
Functional decline of residents
1year
Study Arms (2)
Nursing home with On-line training
EXPERIMENTAL25 randomized residents will be included by nursing home Half of the institutions (randomized too) will benefit from an "on-line" training on the prevention and management of resident lung diseases
Nursing home with usual practice
ACTIVE COMPARATORThis group of Institutions continue their usual practice (routine care) and will not benefit from training during the study period.
Interventions
Nursing teams randomized in the intervention group will benefit from an intervention in the form of a specific training "online" on the prevention of pneumonia and their management in the nursing home This training focuses on prevention, and management during the infectious period (the false food route and the management of pneumonia).
Nursing home with usual practice : The act of comparison is defined by the usual care, as they are performed in the nursing home at the time of the study. No restrictions are placed on residents or caregivers of any kind in the care of the resident.
Eligibility Criteria
You may qualify if:
- Having received information concerning the study and having not expressed opposition to participate,
- For which an agreement in principle of the attending physician has been obtained.
You may not qualify if:
- Refusal of the resident (or of his legal representative) or of his treating physician after given information,
- Resident at the end of life (life expectancy evaluated within one month by the coordinating physician),
- Resident whose attending physician is already involved in the PIANO study under a resident of another nursing home.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Toulouselead
- Ministry of Health, Francecollaborator
Study Sites (1)
University Hospital Toulouse
Toulouse, 31059, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yves Rolland, MD
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2019
First Posted
October 9, 2019
Study Start
October 19, 2020
Primary Completion
June 5, 2023
Study Completion
June 5, 2023
Last Updated
June 18, 2023
Record last verified: 2023-06